Celgene


Global biopharmaceutical company focused on discovering, developing and delivering prescription medicines across oncology, immunology, hematology and cardiovascular disease. Operates worldwide with research and development centered on causal human biology, diverse therapeutic modalities, translational medicine and efforts to accelerate clinical proof of concept and patient access.

Industries

biotechnology
medical

Nr. of Employees

Very Large (1000+)

Celgene

Summit, New Jersey, United States, North America


Products

Commercial portfolio of prescription medicines

A global portfolio of prescription medicines across oncology, immunology, hematology and cardiovascular disease supported by prescribing information and regulatory risk-management materials.


Services

Clinical trial operations and participant matching

End-to-end clinical trial operations and a digital trial-matching platform for researchers and patients.

Medical information and contact center services

Medical information response services and resources for healthcare professionals and patients, including global contact centers.

Pharmacovigilance and safety monitoring

Global adverse event monitoring and reporting, product quality complaint handling and safety governance.

Patient access and support programs

Patient assistance, coverage navigation, translation services and educational resources to support medicine access and adherence.

Medical education grants and training

Funding for continuing medical education, rotations and scientific meetings to support professional development.

Expertise Areas

  • Clinical trial management
  • Pharmacovigilance and drug safety
  • Translational medicine
  • Cell therapy development
  • Show More (6)

Key Technologies

  • Cell therapy (CAR-T)
  • Targeted protein degradation
  • Radiopharmaceutical development
  • Advanced small-molecule chemistry
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.